GlassScriptPhysician profile
Robert Alexander Brevetta
NPI 1871751677
$1,568.84
in general payments reported to CMS, 2019-2025
25 companies · $94.03 in 2025
The $94.03 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $700 · 2020: $153 · 2021: $195 · 2022: $99.35 · 2023: $36.58 · 2024: $292 · 2025: $94.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $255.31 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $159.73 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $120.32 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Alexion Pharmaceuticals, INC. | $114.44 | 2024 | |
| United Therapeutics Corporation | $92.45 | 2021 | |
| Sunovion Pharmaceuticals INC. | $88.56 | 2019 | |
| Edwards Lifesciences Corporation | $77.54 | 2021-2022 | |
| Philips North America LLC | $71.85 | 2019-2020 | |
| Masimo Corporation | $61.25 | 2019-2020 | |
| Insmed, INC. | $55.57 | 2019-2022 | |
| Shionogi INC | $53.42 | 2025 | Fetroja |
| Electromed, INC. | $50.40 | 2022-2023 | Smartvest |
| Genentech USA, INC. | $47.10 | 2019 | |
| Abbvie INC. | $43.90 | 2023-2025 | Avycaz |
| Becton, Dickinson and Company | $38.74 | 2024 | Hemosphere |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.10 | 2019 | |
| Janssen Pharmaceuticals, INC | $31.80 | 2020-2024 | Xarelto |
| Abiomed | $31.61 | 2020 | |
| Talis Clinical LLC | $26.13 | 2024 | |
| Inari Medical, INC. | $26.05 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Grifols USA, LLC | $22.12 | 2019 | |
| Mallinckrodt Hospital Products INC. | $19.56 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.64 | 2020 | |
| Circassia INC. | $14.17 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $13.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brevetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.